Cas 690978-19-9,3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole

690978-19-9

Post Buying Request

Basic information

Product Name: 3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole
Synonyms: 3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole
CAS NO:690978-19-9
Molecular Formula:
Molecular Weight: 368.459
EINECS: N/A
Product Categories: N/A
Mol File: 690978-19-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole(CAS DataBase Reference)
NIST Chemistry Reference: 3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole(690978-19-9)
EPA Substance Registry System: 3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-1,2-benzisothiazole(690978-19-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 690978-19-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

690978-19-9 Suppliers

Recommended suppliersmore

690978-19-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 690978-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,0,9,7 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 690978-19:
(8*6)+(7*9)+(6*0)+(5*9)+(4*7)+(3*8)+(2*1)+(1*9)=219
219 % 10 = 9
So 690978-19-9 is a valid CAS Registry Number.

690978-19-9Upstream product

87691-88-1 3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride

690978-19-9Downstream Products

676118-16-4 4-[2-(4-1,2-benzisothiazol-3-yl-piperazin-1-yl)-ethyl]-phenylamine

690978-19-9Relevant articles and documents

PHENYLALKYL AND PYRIDYLALKYL PIPERAZINE DERIVATIVES

-

Page 35-36, (2010/02/07)

This invention relates to compounds of the formula (1) wherein R1, R3, R4, X1, and X2 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system and other disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 690978-19-9